K. Birch

发表

Abstract P4-13-10: DoBRCA1andBRCA2mutation carriers have an earlier natural menopause than their non-carrier relatives: A study from the Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (kConFab).:

J. Hopper, R. Milne, M. Friedlander, 2012 .

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

J. Hopper, E. John, M. Southey, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.

J. Hopper, R. Milne, M. Friedlander, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin

A. Akbar, M. Rustin, J. Reed, 2005, The British journal of dermatology.

Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo

Sarah E. Jackson, M. Salmon, G. Foster, 2004, The Journal of experimental medicine.

Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T‐cell proliferation in patients with atopic dermatitis

A. Akbar, M. Rustin, J. Reed, 2005, The British journal of dermatology.

Cytomegalovirus-Specific CD4+ T Cells in Healthy Carriers Are Continuously Driven to Replicative Exhaustion1

Arne N. Akbar, Sarah E. Jackson, Milica Vukmanovic-Stejic, 2005, The Journal of Immunology.

Potential control of human immunodeficiency virus type 1 asp expression by alternative splicing in the upstream untranslated region.

J. Mosse, N. Deacon, K. Birch, 2012, DNA and Cell Biology.

The role of regulatory T cells in cutaneous disorders

M. Rustin, J. Reed, M. Vukmanovic‐Stejic, 2005 .

Prospective study of breast cancer risk in mutation-negative women from BRCA1 or BRCA2 mutation-positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).

J. Hopper, R. Milne, M. Friedlander, 2011, Journal of Clinical Oncology.

Replicative Exhaustion Healthy Carriers Are Continuously Driven to Cytomegalovirus-Specific CD4+ T Cells in

M. Salmon, A. Akbar, S. Jackson, 2013 .

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families

J. Hopper, R. Milne, M. Friedlander, 2011, Breast Cancer Research and Treatment.